Risk factor
Very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r
Target Price
The average target price of SFZN.SW is 108 and suggests 51% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell